瘤纳米lysate激活树突细胞,引起预防性免疫反应
Jenna A Dombroski1, Abigail R Fabiano1, Samantha V Knoblauch1
1Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, United States.
Journal of immunological methods
|December 13, 2023
概括
一种新的瘤纳米lysate (TNL) 疫苗通过激活免疫细胞,有望预防三阴性乳腺癌. 在临床前模型中,这种免疫疗法提高了生存率,并延迟了转移.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
背景情况:
- 三阴性乳腺癌 (TNBC) 仍然是一个重要的健康挑战,治疗选择有限.
- 瘤纳米lysate (TNL) 疫苗代表了癌症预防的新方法.
- 了解潜在的免疫机制对于优化TNL疗效至关重要.
研究的目的:
- 为了研究由来自超声波4T1细胞的TNL疫苗引起的免疫反应.
- 阐明涉及TNL介导免疫激活的细胞和分子通路.
- 在体内评估TNL对三阴性乳腺癌的预防潜力.
主要方法:
- 在TNL暴露时对免疫细胞激活 (树突细胞,APC) 的活体分析.
- 在树突细胞中研究TNL细胞和下游信号通路 (NF-kB,c-Fos).
- 在TNL疫苗接种后的小鼠体内时间免疫反应监测.
- 与对照组相比,对TNL疫苗接种的小鼠模型的生存和转移延迟的评估.
主要成果:
- TNL激活了抗原呈现细胞 (APC),包括树突细胞 (DC),导致增强的细胞因子释放.
- DCs细胞化了TNL,激活了NF-kB和c-Fos通路.
- 在体内研究显示,单次TNL剂量后,免疫系统变化持续长达一周.
- 与PBS对照组相比,多次TNL剂量显著提高了生存率,并平均延迟了10天的转移发作.
结论:
- TNL疫苗有效地激活了参与抗瘤反应的关键免疫细胞.
- 观察到的免疫激活途径为TNL疗效提供了机械的洞察力.
- 作为预防三阴性乳腺癌的预防性免疫疗法,TNL显示出显著的潜力.
更多相关视频
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
11.5K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
相关概念视频
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
01:30Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
01:27Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923